This significant paper, published in 2009, provides consensus guidelines for the use of the Freelite serum free light chain assay in the diagnosis and management of plasma cell disorders.The International Myeloma Working Group Guidelines for multiple myeloma include the use of Freelite in:
of patients with AL amyloidosis and multiple myeloma patients with oligosecretory disease.
Leukemia. 2009 Feb;23(2):215-24. doi: 10.1038/leu.2008.307. Epub 2008 Nov 20. Review.